middle.news
Nyrada Launches Phase IIa Xolatryp Trial After Ethics Approval, Eyes March Recruitment
9:02am on Friday 23rd of January, 2026 AEDT
•
Biotechnology
Read Story
Nyrada Launches Phase IIa Xolatryp Trial After Ethics Approval, Eyes March Recruitment
9:02am on Friday 23rd of January, 2026 AEDT
Key Points
Human Research Ethics Committee approval received for Phase IIa trial
Trial to assess safety and preliminary efficacy in heart attack patients
Patient recruitment expected to start March 2026
AU$7.12 million cash balance as of December 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NYR
OPEN ARTICLE